Bioversys tuberculosis combo targets drug resistance
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A new combination treatment for tuberculosis is being developed by Bioversys. The treatment is intended to address drug resistance, a significant challenge in tuberculosis care. The details of the treatment and its potential effectiveness are not specified.